DK438983D0 - Fremgangsmade til fremstilling af n-substituerede benzimidazoler - Google Patents
Fremgangsmade til fremstilling af n-substituerede benzimidazolerInfo
- Publication number
- DK438983D0 DK438983D0 DK4389/83A DK438983A DK438983D0 DK 438983 D0 DK438983 D0 DK 438983D0 DK 4389/83 A DK4389/83 A DK 4389/83A DK 438983 A DK438983 A DK 438983A DK 438983 D0 DK438983 D0 DK 438983D0
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- substituted benzimidazoles
- benzimidazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/424,784 US4492708A (en) | 1982-09-27 | 1982-09-27 | Antiviral benzimidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK438983D0 true DK438983D0 (da) | 1983-09-26 |
Family
ID=23683858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK4389/83A DK438983D0 (da) | 1982-09-27 | 1983-09-26 | Fremgangsmade til fremstilling af n-substituerede benzimidazoler |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4492708A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0111993A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5980666A (cg-RX-API-DMAC7.html) |
| KR (1) | KR840006215A (cg-RX-API-DMAC7.html) |
| AU (1) | AU1956683A (cg-RX-API-DMAC7.html) |
| DD (1) | DD207714A5 (cg-RX-API-DMAC7.html) |
| DK (1) | DK438983D0 (cg-RX-API-DMAC7.html) |
| FI (1) | FI833424A7 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2127408B (cg-RX-API-DMAC7.html) |
| GR (1) | GR79047B (cg-RX-API-DMAC7.html) |
| PL (1) | PL243905A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT77398B (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA836958B (cg-RX-API-DMAC7.html) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4728741A (en) * | 1985-01-08 | 1988-03-01 | Smithkline Beckman Corporation | 1-substituted-2-mercapto benzimidazole compounds and intermediates |
| HU193951B (en) * | 1985-03-11 | 1987-12-28 | Richter Gedeon Vegyeszet | Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them |
| FR2593177B1 (fr) * | 1986-01-20 | 1988-04-01 | Novapharme | Nouveaux benzimidazo |
| SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| US5750532A (en) * | 1986-12-10 | 1998-05-12 | Schering Corporation | Pharmaceutically active compounds |
| US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| US5272167A (en) * | 1986-12-10 | 1993-12-21 | Schering Corporation | Pharmaceutically active compounds |
| AU6062590A (en) * | 1989-07-07 | 1991-02-06 | Schering Corporation | Pharmaceutically active compounds |
| TW203049B (cg-RX-API-DMAC7.html) * | 1990-04-13 | 1993-04-01 | Yamanouchi Pharma Co Ltd | |
| US5602127A (en) * | 1991-02-06 | 1997-02-11 | Karl Thomae Gmbh | (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists |
| US5591762A (en) * | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
| US5594003A (en) * | 1991-02-06 | 1997-01-14 | Dr. Karl Thomae Gmbh | Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists |
| ES2113898T3 (es) * | 1991-06-24 | 1998-05-16 | Neurosearch As | Compuestos de imidazol, su fabricacion y utilizacion. |
| US5210091A (en) * | 1991-06-24 | 1993-05-11 | Neurosearch A/S | Imidazole compounds and their use |
| CA2085844A1 (en) * | 1991-12-27 | 1993-06-28 | Nobuyuki Hamanaka | Fused benzeneoxyacetic acid derivatives |
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| US5399580A (en) * | 1993-03-08 | 1995-03-21 | Burroughs Wellcome Co. | Therapeutic nucleosides-uses |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
| AU3212897A (en) * | 1996-06-05 | 1998-01-05 | Eli Lilly And Company | Anti-viral compounds |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
| NZ334148A (en) * | 1996-08-12 | 2001-12-21 | Celgene Corp | 3-Substituted phenyl-ethyl or ethenyl derivatives terminated with a nitrile, alkane, carboxyl or carbamoyl group useful to reduce cytokine levels |
| AU6031898A (en) * | 1997-01-22 | 1998-08-07 | Eli Lilly And Company | Anti-viral compounds |
| WO1998055120A1 (en) * | 1997-06-04 | 1998-12-10 | Eli Lilly And Company | Anti-viral compounds |
| US5990146A (en) | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
| US7132438B2 (en) * | 2001-10-09 | 2006-11-07 | Amgen Inc. | Benzimidazole derivatives |
| US7470723B2 (en) * | 2003-03-05 | 2008-12-30 | Celgene Corporation | Diphenylethylene compounds and uses thereof |
| AU2004218364A1 (en) * | 2003-03-05 | 2004-09-16 | Celgene Corporation | Diphenylethylene compounds and uses thereof |
| JP4915734B2 (ja) * | 2003-12-18 | 2012-04-11 | テイボテク・フアーマシユーチカルズ | 呼吸器合胞体ウイルス複製阻害剤としてのアミノベンズイミダゾールおよびベンズイミダゾール |
| EP1704145B1 (en) | 2004-01-12 | 2012-06-13 | YM BioSciences Australia Pty Ltd | Selective kinase inhibitors |
| ZA200702380B (en) * | 2004-09-03 | 2008-09-25 | Celgene Corp | Substituted heterocyclic compounds and uses thereof |
| US8921406B2 (en) | 2005-08-21 | 2014-12-30 | AbbVie Deutschland GmbH & Co. KG | 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors |
| FR2892719B3 (fr) * | 2005-11-02 | 2008-01-18 | Sep Innovaterm | Barriere physico-chimique anti-termites constituee par du beton dans lequel a ete incorpore dans toute la masse un insecticide contre les termites |
| US8871746B2 (en) | 2006-03-02 | 2014-10-28 | Kineta Four, LLC | Antiviral drugs for treatment of arenavirus infection |
| EP1988776B1 (en) * | 2006-03-02 | 2012-08-08 | Siga Technologies, Inc. | Antiviral drugs for treatment of arenavirus infection |
| US7977365B2 (en) * | 2006-03-02 | 2011-07-12 | Siga Technologies, Inc. | Antiviral drugs for treatment of arenavirus infection |
| CN101801189B (zh) | 2007-08-27 | 2015-08-26 | 基内塔第四有限责任公司 | 用于治疗沙粒病毒感染的抗病毒药 |
| US20130303782A1 (en) * | 2010-11-24 | 2013-11-14 | Sequent Scientific Limited | Process for preparation of albendazole |
| EP2642995A2 (en) * | 2010-11-24 | 2013-10-02 | Sequent Scientific Ltd. | Process for preparation of triclabendazole |
| WO2016025744A1 (en) * | 2014-08-13 | 2016-02-18 | University Of Virginia Patent Foundation | Cancer therapeutics |
| JP7365332B2 (ja) * | 2017-08-07 | 2023-10-19 | ジョイント・ストック・カンパニー “バイオキャド” | Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物 |
| WO2021189080A1 (en) * | 2020-03-18 | 2021-09-23 | The Board Of Regents Of The University Of Texas System | Methods and compositions for the treatment of influenza |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1384313A (fr) * | 1963-02-09 | 1965-01-04 | Schering Ag | Nouveaux dérivés du benzimidazole et leur préparation |
| GB1045534A (en) * | 1963-02-09 | 1966-10-12 | Schering Ag | New 1-benzyl-5,6-dialkoxy benzimidazoles and a process for their manufacture |
| US3336191A (en) * | 1966-03-11 | 1967-08-15 | Smith Kline French Lab | Anthelmintic 2-amidobenzimidazoles |
| FR1513160A (fr) * | 1966-03-24 | 1968-02-09 | Alfa Laval Ab | Centrifugeuse |
| US3936702A (en) * | 1972-02-24 | 1976-02-03 | Micro Devices Corporation | Electrical protection means |
| US3825537A (en) * | 1972-02-28 | 1974-07-23 | Squibb & Sons Inc | 1-thiazolin-2-yl(or thiazin-2-yl)-2-aminobenzimidazoles and derivatives thereof |
| US3813409A (en) * | 1972-07-31 | 1974-05-28 | Squibb & Sons Inc | Benzimidazolinone compounds |
| US4026936A (en) * | 1975-08-07 | 1977-05-31 | Hoffmann-La Roche Inc. | Anthelmintic pyridine and thiazole substituted benzimidazole carbamates |
| US4174454A (en) * | 1975-08-28 | 1979-11-13 | Eli Lilly And Company | Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles |
| GR61627B (en) * | 1975-08-28 | 1978-12-04 | Lilly Co Eli | Preparation process of carbonyl-substituted 1-sulfonylbenzimidazoles |
| CA1076582A (en) * | 1975-10-28 | 1980-04-29 | Charles J. Paget | Antiviral thiazolinyl or thiazinyl ketobenzimidazoles |
| US4008243A (en) * | 1975-11-19 | 1977-02-15 | Eli Lilly And Company | Antiviral thiazolinyl or thiazinyl benzimidazole esters |
| LU75684A1 (cg-RX-API-DMAC7.html) * | 1976-08-27 | 1978-04-13 | ||
| US4191832A (en) * | 1979-03-12 | 1980-03-04 | Eli Lilly And Company | Separation of syn and anti oximes of 1-sulfonyl-2-aminobenzimidazoles |
| US4230868A (en) * | 1979-04-17 | 1980-10-28 | Eli Lilly And Company | α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles |
| US4316021A (en) * | 1979-08-13 | 1982-02-16 | Eli Lilly And Company | Substituted 1-sulfonylbenzimidazoles |
| US4338329A (en) * | 1979-11-14 | 1982-07-06 | Eli Lilly And Company | Antiviral method employing 1-sulfonylbenzimidazoles |
| US4338315A (en) * | 1979-11-14 | 1982-07-06 | Eli Lilly And Company | Antiviral method employing thiazinyl benzimidazole derivatives |
-
1982
- 1982-09-27 US US06/424,784 patent/US4492708A/en not_active Expired - Fee Related
-
1983
- 1983-09-19 ZA ZA836958A patent/ZA836958B/xx unknown
- 1983-09-19 GR GR72474A patent/GR79047B/el unknown
- 1983-09-22 GB GB08325360A patent/GB2127408B/en not_active Expired
- 1983-09-22 EP EP83305611A patent/EP0111993A3/en not_active Ceased
- 1983-09-23 FI FI833424A patent/FI833424A7/fi not_active Application Discontinuation
- 1983-09-26 PL PL24390583A patent/PL243905A1/xx unknown
- 1983-09-26 KR KR1019830004492A patent/KR840006215A/ko not_active Abandoned
- 1983-09-26 DK DK4389/83A patent/DK438983D0/da not_active Application Discontinuation
- 1983-09-26 PT PT77398A patent/PT77398B/pt unknown
- 1983-09-26 AU AU19566/83A patent/AU1956683A/en not_active Abandoned
- 1983-09-27 DD DD83255127A patent/DD207714A5/de unknown
- 1983-09-27 JP JP58181743A patent/JPS5980666A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1956683A (en) | 1984-04-05 |
| GB2127408A (en) | 1984-04-11 |
| DD207714A5 (de) | 1984-03-14 |
| PT77398A (en) | 1983-10-01 |
| FI833424A0 (fi) | 1983-09-23 |
| FI833424A7 (fi) | 1984-03-28 |
| EP0111993A2 (en) | 1984-06-27 |
| GB8325360D0 (en) | 1983-10-26 |
| EP0111993A3 (en) | 1984-07-25 |
| PT77398B (en) | 1986-03-20 |
| US4492708A (en) | 1985-01-08 |
| KR840006215A (ko) | 1984-11-22 |
| GR79047B (cg-RX-API-DMAC7.html) | 1984-10-02 |
| GB2127408B (en) | 1986-05-14 |
| ZA836958B (en) | 1985-04-24 |
| PL243905A1 (en) | 1985-01-30 |
| JPS5980666A (ja) | 1984-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK438983D0 (da) | Fremgangsmade til fremstilling af n-substituerede benzimidazoler | |
| DK513883A (da) | Fremgangsmaade til fremstilling af aminderivater | |
| DK301383D0 (da) | Fremgangsmade til fremstilling af imidazolderivater | |
| DK1183A (da) | Fremgangsmaade til fremstilling af tiazolidinderivater | |
| DK95483A (da) | Fremgangsmaade til fremstilling af tetrahydropyranderivater | |
| DK241883A (da) | Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater | |
| DK372283A (da) | Fremgangsmaade til fremstilling af desoxyuridinderivater | |
| DK63683D0 (da) | Fremgangsmade til fremstilling af cephemderivater | |
| DK323083D0 (da) | Fremgangsmade til fremstilling af 19-thio-androstanderivater | |
| DK309783A (da) | Fremgangsmaade til fremstilling af organoglykosider | |
| DK435483D0 (da) | Fremgangsmade til fremstilling af fenylcyklobutylderivater | |
| DK427083D0 (da) | Fremgangsmade til fremstilling af cephemderivater | |
| DK261883D0 (da) | Fremgangsmade til fremstilling af prostaglandin-d-derivater | |
| DK119083D0 (da) | Fremgangsmade til fremstilling af alkanoylpyridinoner | |
| DK162230C (da) | Fremgangsmaade til fremstilling af 2-thiacephemderivater | |
| DK317283A (da) | Fremgangsmaade til fremstilling af thiadiazolderivater | |
| DK426683D0 (da) | Fremgangsmade til fremstilling af oxacephalosporinderivater | |
| DK340483D0 (da) | Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater | |
| DK482983D0 (da) | Fremgangsmade til fremstilling af phenylderivater | |
| DK165583A (da) | Fremgangsmaade til fremstilling af furanderivater | |
| DK296383D0 (da) | Fremgangsmade til fremstilling af fenaetylaminer | |
| DK424083A (da) | Fremgangsmaade til fremstilling af anthracyclinglycosider | |
| DK219483A (da) | Fremgangsmaade til fremstilling af anthracyclinglycosider | |
| DK542383D0 (da) | Fremgangsmade til fremstilling af acridanonderivater | |
| DK62283D0 (da) | Fremgangsmade til fremstilling af peptidergotalkaloider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |